NDC properties for "Rebalance (pyrimethamine 12.5 MG/ML / sulfadiazine 250 MG/ML) Oral Suspension" (RxCUI 1309308)
About this data
The tables show NDC propoerties for Rebalance (pyrimethamine 12.5 MG/ML / sulfadiazine 250 MG/ML) Oral Suspension with the RxCUI 1309308
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for Rebalance (pyrimethamine 12.5 MG/ML / sulfadiazine 250 MG/ML) Oral Suspension (RxCUI 1309308)
| NADA | NADA141240 |
|---|---|
| RxCUI | 1309308 |
| SPL_SET_ID | 25ddc8fa-3f23-4786-af2f-db8135d73b09 |
| RXNAV_STR | Rebalance (pyrimethamine 12.5 MG/ML / sulfADIAZINE 250 MG/ML) Oral Suspension |
| RxNorm Name | pyrimethamine 12.5 MG/ML / sulfadiazine 250 MG/ML Oral Suspension [Rebalance] |
| RxNorm Synonym | Rebalance (pyrimethamine 12.5 MG/ML / sulfadiazine 250 MG/ML) Oral Suspension |
| Tallman Synonym | pyrimethamine 12.5 MG/ML / sulfADIAZINE 250 MG/ML Oral Suspension [Rebalance] |
| Tallman Synonym | Rebalance (pyrimethamine 12.5 MG/ML / sulfADIAZINE 250 MG/ML) Oral Suspension |
| Related queries | Interactions (for RxCUI 1309308) |
NDC Properties
NDC Item 49427024711
| NDC 9 | 49427-247 |
|---|---|
| NDC 10 | 49427-247-11 |
| NDC Item | 49427024711 |
| Packaging | 12 BOTTLE in 1 CARTON (49427-247-11) / 946 mL in 1 BOTTLE |
| FDA SPL set id | 756636 |
| Labeler | Pegasus Laboratories, Inc. |
| Label type | PRESCRIPTION ANIMAL DRUG |
| Marketing category | NADA |
| Marketing effective time low | 2004-11-05 |
| Marketing status | ACTIVE |
| NADA | NADA141240 |
| Related queries | Properties for NDC 9 49427-247 |